Anzeige
Mehr »
Login
Montag, 20.09.2021 Börsentäglich über 12.000 News von 674 internationalen Medien
Neue Rekordfahrt? Die große Chance zu Wochenbeginn!?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2P2NP ISIN: US83548R1059 Ticker-Symbol: H3D 
Tradegate
20.09.21
15:11 Uhr
0,511 Euro
-0,017
-3,13 %
1-Jahres-Chart
SONNET BIOTHERAPEUTICS INC Chart 1 Jahr
5-Tage-Chart
SONNET BIOTHERAPEUTICS INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,5030,51816:40

Aktuelle News zur SONNET BIOTHERAPEUTICS Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
31.08.Sonnet BioTherapeutics (SONN) Stock Is a Good Bet for High-Risk Investors24
31.08.Why Sonnet BioTherapeutics Stock Is Trading Higher Today8
31.08.The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical9
SONNET BIOTHERAPEUTICS Aktie jetzt für 0€ handeln
31.08.Sonnet Bio soars on selection of new cancer candidate10
31.08.See Why Sonnet BioTherapeutics Stock Is Skyrocketing In Premarket Tuesday6
30.08.Sonnet BioTherapeutics, Inc.: Sonnet Announces Successful Completion of the Discovery Phase for Its Next Preclinical Pipeline Candidate (SON-1410)434SON-1410 (IL18-FHAB-IL12), a bispecific combination of Interleukins 18 and 12, was selected based on data generated in a mouse melanoma study comparing three bispecific constructsSelection of the asset...
► Artikel lesen
20.08.GeoVax Labs, Flora Growth leads healthcare gainers; Progenity, Sonnet BioTherapeutics among major losers15
20.08.Sonnet BioTherapeutics Stock Slumps After $30M Equity Raise25
20.08.Sonnet Bio secures $30M capital raise30
20.08.Sonnet BioTherapeutics, Inc.: Sonnet BioTherapeutics Announces Pricing of $30 Million Underwritten Public Offering656PRINCETON, NJ / ACCESSWIRE / August 19, 2021 / Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) ("Sonnet" or the "Company"), a biopharmaceutical company developing innovative targeted biologic drugs...
► Artikel lesen
19.08.SONN Stock: The Social Media Buzz Sending Sonnet Bio Rocketing Today9
19.08.Sonnet BioTherapeutics, Ensysce Biosciences leads healthcare gainers; PharmaCyte Biotech, Ontrak among major losers90
19.08.What's Happening With Sonnet BioTherapeutics Stock?11
19.08.Sonnet Bio more than doubles in value amid social media buzz23
16.08.Sonnet BioTherapeutics Holdings, Inc. - 8-K, Current Report7
16.08.Sonnet BioTherapeutics Holdings, Inc. - 10-Q, Quaterly Report5
16.08.Sonnet BioTherapeutics, Inc.: Sonnet BioTherapeutics Provides Fiscal Year 2021 Third Quarter Business and Earnings Update252Sonnet BioTherapeutics Provides Fiscal Year 2021 Third Quarter Business and Earnings UpdateExpanded F H AB Intellectual Property Portfolio Completed $15.9 million At-The-Market Financing SON-1010 and...
► Artikel lesen
15.07.Sonnet BioTherapeutics Holdings, Inc. - 8-K, Current Report9
14.06.Sonnet BioTherapeutics Holdings, Inc. - 8-K, Current Report8
14.06.Sonnet BioTherapeutics, Inc.: Sonnet BioTherapeutics Announces Change in Date of Annual Meeting258Annual Meeting to be Held Thursday July 15, 2021.PRINCETON, NJ / ACCESSWIRE / June 14, 2021 / Sonnet BioTherapeutics Holdings, Inc., (NASDAQ:SONN) a biopharmaceutical company developing innovative targeted...
► Artikel lesen
Seite:  Weiter >>
42 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1